Navigation Search

Collaboration for Comprehensive Care

Our cardiac physicians are leaders in their field, providing the highest level of heart care. Our experienced team continuously enhance this level of advanced care by developing new and better treatments for heart disease through clinical research. These research findings are incorporated to improve cardiac patient outcomes and provide comprehensive care.

Cardiology Clinical Trials


Study Description
ASCEND - HF The purpose of this study is to evaluate whether treatment with the IV drug
Natrecor improves Heart Failure symptoms.
PROTECT This study compares the rate of cardiac stent thrombosis using different types of stents.
PROTECT CA To evaluate overall stent thrombosis rate using the Endeavor Zotarolimus Eluting Coronary Stent System in patients requiring stent implantation.
PLATINUM To purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element Everolimus Eluting Coronary System (Boston Scientific Corp).
MADIT CRT This study is to determine if people who have impaired heart function will have improved survival and less heart failure with an automatic defibrillator device that can also pace the heart efficiently.
SOLID 52 The primary objective of this study is to evaluate  long-term treatment with Darapladib Enteric Coated Tablets when added to standard of care in an acute coronary syndrome (ACS) patients.
PACE-MI The PACE-MI registry is a non-voluntary registry of all patients diagnosed with Myocardial Infarction (MI). In patients with MI discharged from the hospital, beta-blocker dose will be predictive of survival.
Hyponatremia Registry A registry that  identifies  patients hospitalized with hyponatremia and compares the effectiveness of available treatments.
Comparison of Angio Seal and Mynx vascular closure devices after cardiac catheterization via femoral artery The purpose of the study is to investigate the difference of  two FDA-approved vascular closure devices, the Angio Seal and Mynx, after cardiac catheterization.